Showing results (41-50 of 255) with videos related to
Sort By:
Pageof 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2010
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?J C Soria, C Massard, T Le ChevalierBulletin Du Cancer|December 26, 2009
[Targeting KRAS pathway in NSCLC therapy]S Le Moulec, Y Loriot, J-C SoriaAnnals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2014
A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancerS Novello, B Besse, E Felip, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?J C Soria, D Brisgand, T Le ChevalierPathologie-Biologie|June 7, 2006
[Targeting angiogenesis in oncology]J Fayette, J-C Soria, J-P ArmandRevue Des Maladies Respiratoires|April 21, 2010
[ERCC1 and lung cancer]D Planchard, K-A Olaussen, J-C SoriaRevue Des Maladies Respiratoires|July 10, 2013
[Managing nutritional support in thoracic oncology]S Antoun, B Besse, D Planchard, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 1, 1985
Preoperative and postoperative growth rates in acoustic neuromas documented with CT scanningJ Wazen, H Silverstein, H Norrell, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018
Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancerC Ricordel, L Friboulet, F Facchinetti, et al.Advances in Anatomic Pathology|December 30, 1998
Telomerase activity in cancer: a magic bullet or a mirage?J C Soria, P Vielh, A K el-NaggarPageof 26